Last quarter (Q3 2023), Senti Biosciences's total revenue was $338.00K, a decrease of -77.70% from the same quarter last year. In Q3, Senti Biosciences's net income was $-42.41M. See Senti Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21
Total Revenue	$ 3.22M	$ 2.56M	$ 3.29M	-
Cost of Revenue	-	-	-	-
Gross Profit	$ 2.72M	$ 2.56M	$ 3.29M	-
Operating Expense	$ 51.64M	$ 95.29M	$ -74.92M	$ 3.87M
Operating Income	$ -114.78M	$ -92.73M	$ -71.63M	$ -3.87M
Net Non Operating Interest Income Expense	$ 3.57M	$ 2.86M	$ 1.70M	-
Other Income Expense	$ -1.87M	$ -757.00K	$ -11.76M	$ -8.78K
Pretax Income	$ -108.52M	$ -87.37M	$ -58.17M	$ -3.86M
Tax Provision	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-
Net Income Common Stockholders	$ -108.48M	$ -71.06M	$ -58.17M	$ -3.86M
Basic EPS	$ -2.51	$ -3.20	$ -2.23	-
Diluted EPS	$ -2.43	$ -3.20	$ -2.23	$ -0.34
Basic Average Shares	$ 158.93M	$ 44.37M	$ 26.11M	$ 22.29M
Diluted Average Shares	$ 158.93M	$ 44.37M	$ 26.11M	-
Dividend Per Share	-	-	-	-
Total Operating Income As Reported	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-
Rent Expense Supplemental	-	-	-	-
Total Expenses	$ 51.64M	$ 95.29M	$ -74.92M	$ 3.87M
Net Income From Continuing And Discontinued Operation	$ -81.03M	$ -71.06M	$ -58.17M	$ -3.86M
Normalized Income	$ -22.72M	$ -43.26M	-	-
Interest Expense	-	-	-	-
EBIT	$ -109.66M	$ -87.37M	$ -58.17M	$ -3.86M
EBITDA	$ -106.13M	$ -83.01M	$ -54.60M	$ -3.86M

Currency in USD

Senti Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing